Commentary: The price of pleurodesis: The impact of pleurodesis on lung function.

JTCVS Open

Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.

Published: March 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390437PMC
http://dx.doi.org/10.1016/j.xjon.2021.01.006DOI Listing

Publication Analysis

Top Keywords

commentary price
4
price pleurodesis
4
pleurodesis impact
4
impact pleurodesis
4
pleurodesis lung
4
lung function
4
pleurodesis
2
commentary
1
impact
1
lung
1

Similar Publications

The health care price crisis needs policy solutions.

Am J Manag Care

December 2024

Catalyst for Payment Reform. Email:

This commentary, part of the Price Crisis campaign, calls for state and federal policy interventions that are needed to rebalance the market to enhance competition and provide value in health care.

View Article and Find Full Text PDF

Exploring opposing arguments in the call for randomized controlled trials to demonstrate benefit of Mohs micrographic surgery for cutaneous melanoma.

Dermatol Online J

October 2024

Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.

The call for robust randomized clinical trials (RCTs) comparing Mohs micrographic surgery (MMS) with wide local excision for treatment of melanoma has stymied the development of guidelines for MMS despite growing evidence of benefit. This commentary explores the controversy by detailing opposing arguments, reviewing the relevant evidence supporting the use of MMS for early-stage melanoma, and discussing the role that RCTs may play in development of national guidelines for surgical treatment options for melanoma. Randomized clinical trials are considered the gold standard of clinical research, but there are no such trials currently to support MMS for melanoma.

View Article and Find Full Text PDF

When built environments in health care result from an evidence-based design (EBD) process, they are interventions that can improve patients' health outcomes. This commentary on a case discusses which ethical values should guide organizations' capital expenditure decisions about retrofits, which might be more costly than the original budget. This discussion urges reevaluation of the common assumption that capital improvements are "sunk costs," since such improvements can promote long-term positive health outcomes for an organization's patients, thereby advancing both financial value and ethical values.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!